168 related articles for article (PubMed ID: 2680866)
1. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
Brook MG; Karayiannis P; Thomas HC
Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis B virus infection with interferon. Factors predicting response to interferon.
Thomas HC; Karayiannis P; Brook G
J Hepatol; 1991; 13 Suppl 1():S4-7. PubMed ID: 1960378
[TBL] [Abstract][Full Text] [Related]
3. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
McDonald JA; Caruso L; Karayiannis P; Scully LJ; Harris JR; Forster GE; Thomas HC
Hepatology; 1987; 7(4):719-23. PubMed ID: 3038722
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
5. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
[TBL] [Abstract][Full Text] [Related]
6. Recombinant leukocyte interferon treatment of chronic hepatitis B.
Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
[TBL] [Abstract][Full Text] [Related]
8. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
10. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.
Dooley JS; Davis GL; Peters M; Waggoner JG; Goodman Z; Hoofnagle JH
Gastroenterology; 1986 Jan; 90(1):150-7. PubMed ID: 3940241
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy.
Saracco G; Mazzella G; Rosina F; Cancellieri C; Lattore V; Raise E; Rocca G; Giorda L; Verme G; Gasbarrini G
Hepatology; 1989 Sep; 10(3):336-41. PubMed ID: 2668148
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of a low dosage of human leukocyte interferon on chronic hepatitis B virus infection.
Matsumura N; Yoshikawa T; Kondo M; Kawakami H; Kishida T
Digestion; 1983; 26(4):205-12. PubMed ID: 6873506
[TBL] [Abstract][Full Text] [Related]
14. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).
Krogsgaard K; Bindslev N; Christensen E; Craxi A; Schlichting P; Schalm S; Carreno V; Trepo C; Gerken G; Thomas HC
J Hepatol; 1994 Oct; 21(4):646-55. PubMed ID: 7814812
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.
Brook MG; Chan G; Yap I; Karayiannis P; Lever AM; Jacyna M; Main J; Thomas HC
BMJ; 1989 Sep; 299(6700):652-6. PubMed ID: 2508850
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
[TBL] [Abstract][Full Text] [Related]
19. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
20. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]